文献速递中枢神经肿瘤放疗姑息放疗与转移瘤

识别可能无法从全脑放疗中获益的脑转移患者的风险因素——一项单中心分析

Risk factors to identify patients who may not benefit from whole brain irradiation for brain metastases - a single institution analysis.
PubMed 文献 · Radiat Oncol · 2019-03-11

该单中心分析纳入2009年1月至2016年1月接受全脑放疗(33 Gy/11次,每周4次)的339例脑转移患者,中位生存期2.5个月;发现KPS<70、年龄>70岁、颅内转移灶>3个、原发肿瘤未控制4个风险因素与中位生存期显著负相关,具有3–4个风险因素者中位生存期仅0.4个月。

要点

  • 339例全脑放疗脑转移患者中位生存期2.5个月(范围0–61个月)。
  • KPS<70、年龄>70岁、颅内转移灶>3个、原发肿瘤未控制与中位生存期显著负相关。
  • 无风险因素者中位生存4.7个月,3–4个风险因素者仅0.4个月(p<0.00001)。

核心结论

  • 具有上述风险因素的患者全脑放疗后总生存可能受到负面影响,若具备3–4个风险因素可较容易地预测其不会从全脑放疗中获益。

研究设计与样本

  • 单中心分析,共分析339例2009年1月至2016年1月接受全脑放疗的脑转移患者记录。
  • 采用外照射技术全脑给予33 Gy分11次(每周4次)。
  • 用Kaplan-Meier法分析8个可能影响生存的临床因素,单因素分析P<0.05者进入Cox回归多因素分析。

主要发现

  • 339例患者中位生存期2.5个月(范围0–61个月)。
  • KPS<70、年龄>70岁、颅内转移灶>3个、原发肿瘤未控制为显著且与中位生存期负相关的风险因素。
  • 无风险因素者中位生存4.7个月,1个风险因素者2.5个月,2个风险因素者2.3个月,3–4个风险因素者0.4个月(p<0.00001)。

关键数值与推荐

  • 全脑放疗剂量方案为33 Gy分11次,每周4次。
  • 风险因素包括KPS<70、年龄>70岁、颅内转移灶>3个、原发肿瘤未控制。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Radiotherapy plays a major role in the management of brain metastases. This study aimed to identify the subset of patients with multiple brain metastases who may not benefit from whole brain irradiation (WBI) due to a short survival time regardless of treatment. METHODS: We analyzed a total of 339 patient records with brain metastases treated with whole brain radiotherapy from January 2009 to January 2016. External beam radiotherapy techniques were used to deliver 33 Gy in 11 fractions (4 fractions per week) to the whole brain. Eight clinical factors with a potential influence on survival were investigated using the Kaplan-Meier method. All factors with a P < 0.05 in univariate analysis were entered into multivariate analysis using Cox regression. RESULTS: In the present series of 339 patients, median survival time was 2.5 months (M; range, 0-61 months). Four risk factors Karnofsky Performance Score (KPS) < 70, age > 70, > 3 of metastases intracranial, uncontrolled primary tumor) were identified that were significant and negatively correlated with median survival time. Patients with no risk factors had a median survival of 4.7 M; one risk factor, 2.5 M; two risk factors, 2.3 M; and 3-4 risk factors, 0.4 M (p < 0.00001). CONCLUSIONS: Patients with identified risk factors might have a negatively impacted overall survival after WBI. Accordingly, patients who will not benefit from WBI can be easily predicted if they have 3-4 of these risk factors.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Buecker R, Hong ZY, Liu XM, et al. Risk factors to identify patients who may not benefit from whole brain irradiation for brain metastases - a single institution analysis. Radiat Oncol. 2019. PMID: 30866972. doi:10.1186/s13014-019-1245-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。